Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community. These blogs are an opportunity for ophthalmic bloggers to engage with readers with about a topic that is top of mind, whether it is practice management, experiences with patients, the industry, medicine in general, or healthcare reform. The series continues with this blog by Joshua Mali, MD. The views expressed in these blogs are those of their respective contributors and do not represent the views of Ophthalmology Times or MultiMedia Healthcare, LLC.
I am happy to announce a new initiative by the Macular Degeneration Association (MDA): AMD Centers of Excellence (COE). This program shares best-practice methods in disease evaluations and treatments. This age-related macular degeneration (AMD) COE will help patients locate outstanding treatment facilities in their area.
Founded in 2007, the MDA is a nonprofit health organization dedicated to educating and empowering patients with AMD. The MDA funds research, publishes scientific findings, and provides funding for AMD awareness programs. The association is also involved in advocating for scientific research and the rights of people with AMD.
As a keynote speaker for the organization, I have had the joy of participating in patient education programs. These programs allow AMD patients and their family/caretakers to take control of their disease through education.
Joshua Mali, MD
E: [email protected]
Dr. Mali is the founder & CEO of Mali Enterprises. His relevant financial disclosures include the following: speaker, consultant, and medical director of the Macular Degeneration Association (MDA).